MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Net income (loss)
    • Customer funds payable
    • Share-based compensation expense
    • Others
Negative Cash Flow Breakdown
    • Change in fair value of transche...
    • Proceeds from issuance of conver...
    • Investment in transchem warrant
    • Others
Cash Flow
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Net income (loss)
80,841
-11,650
-95,163
-23,154
Depreciation and amortization
1,052
66
80
153
Change in fair value of contingent consideration liability
-
-
0
-
Non-cash lease expense
0
0
63
266
Share-based compensation expense
1,892
2,805
53,806
8,116
Unit-based compensation expense
-
-
0
-
Forfeiture and cancellation of common units
-
-
0
-
Impairment of long-lived assets
1,246
-
253
708
Loss on sale of businesses
-
-
-22,663
-
Gain on lease terminations
-
-
8,884
-
Goodwill and intangible assets impairments
-
-
0
-
Loss on sale of bakkt trust
0
-
2,301
0
Loss on extinguishment of convertible debenture
-
-
0
-2,617
Gain on lease assignment
0
-1,755
-
0
Change in fair value of warrant liability
-1,416
-4,700
-43,734
37,187
Change in fair value of derivative assets
-
-
13,973
-
Loss on equity method investment
-283
-221
-323
-
Change in fair value of transchem warrant and derivative asset
-98,337
43,867
-
-43,350
Tra equity settlement
-
-
22,983
-
Professional fees paid in stock
1,125
-
-
-
Other
-58
-
-1
-450
Accounts receivable
1,849
-1,500
-6,084
8,993
Prepaid insurance
-742
-1,082
-1,211
1,892
Deposits with clearing house
0
-
2,500
-
Accounts payable and accrued liabilities
-2,906
-2,123
-1,787
-6,944
Unsettled crypto trades
546
-1,850
-
-
Due to related party
0
0
2
0
Deferred revenue
24
-769
-19
402
Operating lease liabilities
-102
-471
-563
-874
Proceeds from the maturity of marketable securities
-
-
55,000
0
Customer funds payable
3,189
2,731
3,601
-10,275
Proceeds from sale of bakkt trust
-
-
0
0
Assets and liabilities of businesses held for sale
0
0
-192
0
Purchase of intangible assets
-
-
0
2,650
Other assets and liabilities
1,205
-548
-1,744
1,074
Purchase of equity method investment
-
-
0
11,472
Net cash used in operating activities
-14,817
-12,093
-10,813
-46,657
Cash paid for loyalty divestiture
-
-
-20,146
-
Capitalized internal-use software development costs and other capital expenditures
1,259
25
-
703
Cash advance for loyalty buyer
-
-
17,591
-
Proceeds from sale of bakkt trust
0
-
-
-
Cash received from settlement of derivative arrangement
0
2,677
10,621
-
Purchase of investments
0
14
50,141
5,094
Consideration for the acquisition of dtr
3,200
-
-
-
Consideration for the acquisition of gyzer
253
-
1,167
-
Acquisition, net of cash acquired-Bumped Financial LLC
-
-
0
-
Investment in swan
250
-
-
-
Acquisition, net of cash acquired-Apex Crypto LLCBakkt Crypto Solutions LLC
-
-
0
-
Investment in transchem warrant
9,410
-
-
-
Net cash (used in) provided by investing activities
-14,372
1,935
-22,721
-19,770
Proceeds from concurrent offerings, net of issuance costs
-
-
0
0
Withholding tax payments on net share settlements on equity awards
-
-
3,071
-
Proceeds from the exercise of warrants
0
0
0
0
Withholding tax payments on net share settlements on equity awards
49
-3,137
-
1,705
Proceeds from equity offerings
0
69,602
-
-
Cash paid for equity offerings
0
2,541
-
-
Exercise of stock options
500
-
384
-
Proceeds from common stock issuance, net of issuance cost
-
-
0
62,961
Proceeds from the exercise of warrants-Pre Funded Warrants
-
-
0
7,464
Repayment of convertible debenture
-
-
0
7,875
Proceeds from borrowings on revolving credit facility
0
0
0
0
Repayments on revolving credit facility
0
-
0
0
Cash paid for financing costs
0
-
755
-
Proceeds from issuance of convertible debentures, net of discounts
-
-
23,750
-
Proceeds from issuance of convertible debentures, net of issuance costs
-22,220
-
-
-1,530
Net cash provided by financing activities
451
66,781
730
60,090
Effect of exchange rate changes
-40
94
1
-323
Net increase (decrease) in cash, cash equivalents, restricted cash, customer funds and deposits
-28,778
56,717
-32,803
-6,660
Cash, cash equivalents, restricted cash, customer funds and deposits at the beginning of the period
101,619
44,902
77,705
153,746
Cash, cash equivalents, restricted cash, customer funds and deposits at the end of the period
72,841
-
-
-
Non-cash operating lease right-of-use asset acquired
82
-
-
-
Non-cash acquisition consideration
103,661
-
-
-
Cash and cash equivalents
49,980
-
-
-
Restricted cash
718
-
-
-
Customer funds
20,582
-
-
-
Deposits (note 7)
1,561
-
-
-
Total cash, cash equivalents, restricted cash, customer funds and deposits
72,841
101,619
44,902
77,705
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

something is missing$22,220K Exercise of stock options$500K Net cash provided byfinancing activities$451K (-97.88%↓ Y/Y)Canceled cashflow$22,269K Net increase(decrease) in cash, cash...-$28,778K (58.52%↑ Y/Y)Canceled cashflow$451K Net income (loss)$80,841K (680.96%↑ Y/Y)Customer funds payable$3,189K (104.74%↑ Y/Y)Share-based compensationexpense$1,892K (-80.46%↓ Y/Y)Impairment of long-livedassets$1,246K Professional fees paid instock$1,125K Depreciation andamortization$1,052K (181.28%↑ Y/Y)Prepaid insurance-$742K (61.03%↑ Y/Y)Unsettled crypto trades$546K Loss on equity methodinvestment-$283K Other-$58K (33.33%↑ Y/Y)Deferred revenue$24K (104.49%↑ Y/Y)Proceeds from issuance ofconvertible debentures, net...-$22,220K (-193.56%↓ Y/Y)Withholding tax payments onnet share...$49K (-97.14%↓ Y/Y)Net cash used inoperating activities-$14,817K (84.55%↑ Y/Y)Net cash (used in)provided by investing...-$14,372K (-428.95%↓ Y/Y)Canceled cashflow$90,998K Effect of exchange ratechanges-$40K (-104.37%↓ Y/Y)Change in fair value oftranschem warrant and...-$98,337K Investment in transchemwarrant$9,410K Consideration for theacquisition of dtr$3,200K Capitalized internal-usesoftware development...$1,259K (744.97%↑ Y/Y)Consideration for theacquisition of gyzer$253K Investment in swan$250K Accounts payable andaccrued liabilities-$2,906K (-180.90%↓ Y/Y)Accounts receivable$1,849K (210.59%↑ Y/Y)Change in fair value ofwarrant liability-$1,416K (94.01%↑ Y/Y)Other assets andliabilities$1,205K (144.42%↑ Y/Y)Operating leaseliabilities-$102K (96.22%↑ Y/Y)

Bakkt, Inc. (BKKT-WT)

Bakkt, Inc. (BKKT-WT)